Abstract

Inflammatory diseases of the female genital area are dominant among the total number of gynecological diseases. Among all the variety of medicinal plant materials used in official medicine, salvia medicinal draws attention to itself, which has repeatedly proved its effectiveness in the treatment of inflammatory diseases of the mucous membranes of various origins. That is why the goal was set to develop a technology for obtaining a liquid extract from the leaves of Salvia officinalis L. As a result of the study, a method was developed for obtaining a liquid extract by selecting the optimal extraction conditions. It was found that the optimal raw material-extractant ratio is 1:50, the optimal concentration of the extractant ethyl alcohol is 70%, the infusion time of the extract is 24 hours. To intensify the extraction process, the method of ultrasonic processing of raw materials at the soaking stage was used. The optimal time for processing plant materials with ultrasound was 45 minutes. As a result of using this method to obtain a liquid extract from the leaves of sage officinalis, the yield of phenolic compounds was doubled in comparison with obtaining an extract without sonication of raw materials and amounted to 182.7 mg / g of flavonoids in terms of luteolin-7-glycoside.

Highlights

  • According to the analysis of the pharmaceutical market in the Russian Federation, about 25% of all drugs are herbal drugs [1]

  • Medicinal herbal raw materials for the treatment of vulvitis and vulvovaginitis are represented by fees and account for only 4% of the total market share of medicines

  • That is why the purpose of this work was to develop a technology for obtaining a liquid extract from the leaves of Salvia officinalis L

Read more

Summary

Introduction

According to the analysis of the pharmaceutical market in the Russian Federation, about 25% of all drugs are herbal drugs [1]. Analysis by groups of dosage forms showed that soft dosage forms rank first and account for 47% of the total number of drugs. The leaders in this group are suppositories with a market share of 87%, including vaginal ones - 62%. Medicinal herbal raw materials for the treatment of vulvitis and vulvovaginitis are represented by fees and account for only 4% of the total market share of medicines. As the assortment analysis of the domestic drug market has shown, there is currently a shortage of herbal remedies for the treatment of vulvitis

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.